Urdu Translation and Validation of Michigan Hand Outcome Questionnaire

June 26, 2023 updated by: Riphah International University
Aim of this study to provide a urdu version of Michigan Hand Outcome Questionnaire, that will be more understandable for Pakistani People.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Because of these unique qualities, the MHQ has become one of widely used tools by the clinicians to assess quality-of-life relevant to functioning of hands and upper limb. It has also been translated to many other languages from the original English version for an easy understanding and adaptation into the local population. despite being its availability in approximately 20 different languages., the Urdu translation of this questionnaire has not yet been published anywhere. Urdu is Pakistan's official language, and the majority of Pakistanis are unable to understand this subjective assessment questionnaire originally written in English. It is required to translate the questionnaire into Urdu for Pakistanis people as the upper limb disorders are one of the most prevalent musculoskeletal disorders in Pakistan. Urdu translation of Michigan Hand Outcomes Questionnaire will help the Pakistan population with hand disorders to describe their pain or disability experience clearly. The Clinical physiotherapists of Pakistan can be capable of capturing the subjective health states of Pakistani patients with hand disorders more conveniently using the Urdu translated MHQ.

Study Type

Observational

Enrollment (Estimated)

140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • Punjab
      • Jhang, Punjab, Pakistan, 35200
        • District Health quarter jhang
        • Contact:
        • Principal Investigator:
          • Alishfa Zahoor, MS-OMPT
        • Sub-Investigator:
          • Saba Rafique, Masters

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All the participants with upper limb and hand disorders will be required to fill the urdu version of michigan hand outcome questionnaire.

Description

Inclusion Criteria:

  • • Patients with conditions and diseases of the Hand and the Upper extremity (arthritis, trauma etc.).

    • Both genders of age 18 and over
    • Patients who are willing to fill study questionnaires.

Exclusion Criteria:

  • • Unable to read or write in Urdu

    • People with cognitive dysfunction
    • People with Any neurological disorder
    • Unable to fill questionnaire independently

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Each question of Urdu version of Michigan hand outcome questionnaire
Time Frame: 6-8 weeks
AS its a validity and reliability study so each question of questionnaire will be outcome
6-8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Each question of Urdu version of SF-36 questionnaire
Time Frame: 6-8 Weeks
AS its a validity and reliability study so each question of questionnaire will be outcome
6-8 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Saba Rafique, Masters, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2023

Primary Completion (Estimated)

July 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

June 26, 2023

First Submitted That Met QC Criteria

June 26, 2023

First Posted (Actual)

July 5, 2023

Study Record Updates

Last Update Posted (Actual)

July 5, 2023

Last Update Submitted That Met QC Criteria

June 26, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • REC/0029 Alishfa zahoor

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Extremity Problem

Clinical Trials on NO INTERVENTION

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe